IGT v. Zynga Inc., Appeal No. 2023-2262 (Fed. Cir. July 22, 2025)
In this week’s Case of the Week, the Federal Circuit examined the reviewability and merits of the Patent Trial Appeal Board’s decision to institute inter...more
This week, we take a closer look at two precedential cases concerning pharmaceutical patent protections as applied to drugs in development.
In Incyte Corp. v. Sun Pharm., Judge Hughes entered a dissent pushing back on the...more
5/13/2025
/ Appeals ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Hatch-Waxman ,
Injunctive Relief ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Remand ,
USPTO
Apple Inc. v. Gesture Technology Partners, LLC, Appeal Nos. 2023-1475, -1533 (Fed. Cir. Mar. 4, 2025)
Our Case of the Week is a high-stakes appeal from an inter partes review concerning a patent titled “Camera Based...more
3/11/2025
/ Appeals ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Remand ,
Technology ,
USPTO ,
Vacated